Thursday, May 17, 2007

They are gonna have to come up with a better name.

More than 7 years after Viagra hit the market, women are still asking: "What about us?"

Now in clinical trials, Flibanserin, originally investigated as an antidepressant, shows signs of being the answer to that question.

Low libido has never been a problem for me, but I have to comment on at least one thing. If this stuff is going to make it to the mainstream, it's going to need a better name.

I suggest we give it a name derived from one of our libidinous heroines from "Desperate Housewives" or "Sex and the City". sCarrieSex or SammanticEvening, maybe. We could honor our soon to be departed, Queen-of-England-endorsed president, and call it BurningBush. I kind of like that one. After all, we're going to remove the "Proud home of President George W. Bush" from our "Welcome to Texas" signs. That will put him on the lips of more women than Bill Clinton.

The
WFAA news article goes on to say:

Instead of increasing hormone levels, Flibanserin targets the pleasure zones of a woman's brain.

For this phase three study, researchers are looking for pre-menopausal women, between 18-to-45 years old, in a stable, heterosexual relationship, with no other serious medical conditions.

I don't know about you, but my pleasure zones include the mall, fine restaurants, expensive cars, and good hydro. Just kidding, Mom.

I guess those horny lesbians are SOL.

Saturday, May 5, 2007

In Politics

Everyone is someone's bitch.